This study is to assess the efficacy and safety of YM178 in patients with symptoms of overactive bladder.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
1,126
Unnamed facility
Beijing, China
Unnamed facility
Dalian, China
Change in mean number of micturitions per 24 hrs
Time frame: Within a 12-week treatment period
Change in mean number of urgency episodes per 24 hrs
Time frame: Within a 12-week treatment period
Change in mean number of urinary incontinence episodes per 24 hrs
Time frame: Within a 12-week treatment period
Change in mean number of urge incontinence episodes per 24 hrs
Time frame: Within a 12-week treatment period
Change in mean volume voided per micturition
Time frame: Within a 12-week treatment period
Change in mean number of nocturia episodes
Time frame: Within a 12-week treatment period
Safety assessed by vital signs, adverse events laboratory findings, 12-lead electrocardiogram and post-void residual volume
Time frame: During 12-week treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Fuzhou, China
Unnamed facility
Guangzhou, China
Unnamed facility
Hangzhou, China
Unnamed facility
Hubei, China
Unnamed facility
Hunan, China
Unnamed facility
Jiangsu, China
Unnamed facility
Liaoning, China
Unnamed facility
Nanjing, China
...and 25 more locations